SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-18-006949
Filing Date
2018-05-29
Accepted
2018-05-29 16:01:27
Documents
4
Period of Report
2018-05-29

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k052918_biondvaxpharma.htm 6-K 21406
2 PRESS RELEASE DATED MAY 29, 2018 f6k052918ex99-1_biondvax.htm EX-99.1 118850
3 BIONDVAX PHARMACEUTICALS LTD. UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD ENDE f6k052918ex99-2_biondvax.htm EX-99.2 429663
4 GRAPHIC ex99-1img_001.jpg GRAPHIC 14661
  Complete submission text file 0001213900-18-006949.txt   591242
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 18864408
SIC: 2836 Biological Products, (No Diagnostic Substances)